As a result, patients undergoing peptide therapy for recovery often report improved mobility, reduced pain, and faster functional restoration
Patients with a BMI of 27 or higher who struggle with high blood pressure, insulin resistance, or cholesterol may also qualify
Retatrutide is a triple agonist: it activates the GLP-1 receptor plus two more, GIP and glucagon
When new treatments are approved, we will evaluate them for inclusion in our clinical protocols based on the evidence, not the hype
So, the modern medical solution to this mismatch between the foods we were built to eat, that naturally activate satiety circuits, and the processed junk were now being sold is to physically, surgically change our anatomy to force it to the end of our gut, or inject GLP-1 mimicking drugs, so we get GLP-1 activation regardless of what we eat
"Now, where we get concerned is when this is happening without any guidance from a medical professional." Why are people 'microdosing' Ozempic, other weight-loss drugs